Publications from the Center Data Science Shared Resource in conjunction with Cancer
Center members.
Published
Graff S, Subbiah I, Markham M, Matt-Amaral L, Close J, Griffith K, Jagsi R, Frequency,
barriers, outcomes, and consequences of reporting sexual harassment in clinical oncology,
JNCI Cancer Spectrum, 2023 Jan 3;7(1):pkac081, PMID: 36416149, PMCID: PMC9808769,
doi: 10.1093/jncics/pkac081
Al-Holou W, Wang H, Rivikumar V, Shankar S, Oneka M, Fehmi Z, Verhaak R, Kim H, Pratt
D, Camelo-Piragua S, Speers C, Wahl D, hollon T, Sagher O, Heth J, Muraszko K, Lawrence
T, Carvalho A, Mikkelsen T, Rao A, Rehemtulla A, Subclonal evolution and expansion
of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma,
Neoplasia, 2023 Jan 6;36:100872, PMID: 36621024, PMCID: , doi: 10.1016/j.neo.2022.100872
Phung M, Webb P, DeFazio A, Fereday S, Lee A, Bowtell D, Fasching P, Goode E, Goodman
M, Karlan B, Lester J, Matsuo K, Modugno F, Brenton J, Gorp T, Pharoah P, Schuldkraut
J, McLean K, Meza R, Mukherjee B, Richarson J, Grout B, Chase A, Deurloo C, Terry
K, Hanley G, Pike M, Berchuck A, Ramus S, Pearce C, Lifestyle and personal factors
associated with having macroscopic residual disease after ovarian cancer primary cytoreductive
surgery, Gynecol Oncol, 2023 Jan;168:68-75, PMID: 36401943, PMCID: , doi: 10.1016/j.ygyno.2022.10.018
Hawley S, Kidwell K, Zahrieh D, McCarthy A, Wills R, Rankin A, Hofer T, Chow S, Jagsi
R, Neuman H, Improving patient-centered communication in breast cancer: a study protocol
for a multilevel intervention of a shared treatment deliberation system (SharES) within
the NCI community oncology research program (NCORP) (Alliance A231901CD), Trials,
2023 Jan 6;24(1):16., PMID: 36609349, PMCID: PMC9817354, doi: 10.1186/s13063-022-07048-4
Vince R, Jiang R, Bank M, Quarles J, Patel M, Sun Y, Hartman H, Zaorsky N, Jia A,
Shoag J, Dess R, Mahal B, Stensland K, Eyrich N, Seymore M, Takele R, Morgan T, Schipper
M, Spratt D, Evaluation of Social Determinants of Health and Prostate Cancer Outcomes
Among Black and White Patients: A Systematic Review and Meta-analysis, JAMA Network
Open, 2023 Jan 3;6(1):e2250416, PMID: 36630135, PMCID: ,
Hammer L, Jiang R, Hearn J, Lashbrook J, Mitchell A, Daignault-Newton S, Dess R, Jackson
W, Reichert Z, Alumkal J, Kaffenberger S, George A, Montgomery J, Salami S, Morgan
T, Miller D, Wittman D, Hollenbeck, Mehra R, Davenport M, Sun Y, Schipper M, Palapattu
G, Spratt D, A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to
Radical Prostatectomy for Locally Advanced Prostate Cancer, Int J Radiat Oncol Biol
Phys, 023 Jan 1;115(1):132-141, PMID: , PMCID: ,
Wages N, Braun T, Conaway M, Isotonic design for phase I cancer clinical trials with
late-onset toxicities, J Biopharm Stat, 2023 Jan 6;1-14., PMID: 36606874, PMCID: ,
doi: 10.1080/10543406.2022.2162068
Stensland et al, Better Understanding the Timing Of Androgen Deprivation Trial Outcomes:
Impacts of Prior Androgen Deprivation Therapy, JNCI Cancer Spectr, 2022 May 2;6(3):pkac025.,
PMID: 35616109, PMCID: PMC9134272, doi: 10.1093/jncics/pkac025
Vo J, Wu Y, Mishler J, Hall S, Mannan R, Waqng L, Ning Y Zhau J, Hopkins A, Estill
J, Chan W, Yesel J, Cao X, Rao A, Tsodikov A, Talpaz M, Cole C Ye J, Auclair D, Cho
H, Robinson D, Chinnaiyan, The genetic heterogeneity and drug resistance mechanisms
of relapsed refractory multiple myeloma, Nature Communications, 2022 Jun 29;13(1):3750,
PMID: 35768438, PMCID: PMC9243087, doi: 10.1038/s41467-022-31430-0
Harper D, Plegue M, Jimbo M, Gorin S, Sen A, US women screen at low rates for both
cervical and colorectal cancers than a single cancer: a cross-sectional population-based
observational study, Elife, 2022 Jun 28;11:e76070, PMID: 35762572, PMCID: PMC9239676,
doi: 10.7554/eLife.76070
Waljee A, Weinheimer-Hau E, Abubakar A, Ngugi A, Siwo G, Kwakye G, Singal A, Rao A,
Saini S, Read A, Baker J, Balis U, Opio C, Zhu J, Saleh M, Artificial intelligence
and machine learning for early detection and diagnosis of colorectal cancer in sub-Saharan
Africa, Gut, 2022 Jul;71(7):1259-1265, PMID: 35418482, PMCID: PMC9177787, doi: 10.1136/gutjnl-2022-327211
Krishnan S, Mohammed S, Frankel T, Rao A, GaWRDenMap: a quantitative framework to
study the local variation in cell-cell interactions in pancreatic disease subtypes,
Sci Rep, 2022 Mar 8;12(1):3708, PMID: 35260589, PMCID: PMC8904504, doi: 10.1038/s41598-022-06602-z
Najem et al, Central nervous system immune interactome is a function of cancer lineage,
tumor microenvironment, and STAT3 expression, JCI Insight, 2022 May 9;7(9):e157612,
PMID: 35316217, PMCID: PMC9090258, doi: 10.1172/jci.insight.157612
Abousamra et al, Deep Learning-Based Mapping of Tumor Infiltrating Lymphocytes in
Whole Slide Images of 23 Types of Cancer, Front Oncol, 2022 Feb 16;11:806603, PMID:
35251953, PMCID: PMC8889499, doi: 10.3389/fonc.2021.806603
Masudo et al, Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients
Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy, JCO
Precision Oncology, 2022 Mar;6:e2000368, PMID: 35294223, PMCID: PMC8939918, doi: 10.1200/PO.20.00368
Lee et al, Unsupervised machine learning for identifying important visual features
through bag-of-words using histopathology data from chronic kidney disease, Sci Rep,
2022 Mar 22;12(1):4832, PMID: 35318420, PMCID: PMC8941143, doi: 10.1038/s41598-022-08974-8
Qin et al, Cellular engagement and interaction in the tumor microenvironment predict
non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer, Sci
Rep, 2022 May 31;12(1):9054, PMID: 35641540, PMCID: PMC9156701, doi: 10.1038/s41598-022-13236-8
Pati et al, Federated learning enables big data for rare cancer boundary detection,
Nature Communications, 2022 Dec 5;13(1):7346, PMID: 36470898, PMCID: PMC9722782, doi:
10.1038/s41467-022-33407-5
Haase et al, H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated
immune responses in pediatric high-grade glioma models, Journal of Clinical Investigation,
2022 Nov 15;132(22):e154229, PMID: 36125896, PMCID: PMC9663161, DOI: 10.1172/JCI154229
Mello et al, Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic
cancer, Oncogenesis, 2022 Sep 15;11(1):56, PMID: 36109493, PMCID: PMC9478137, DOI:
10.1038/s41389-022-00434-2
Griffith et al, MHC Class II Expression Influences the Composition and Distribution
of Immune Cells in the Metastatic Colorectal Cancer Microenvironment, Cancer (Basel),
2022 Aug 24;14(17):4092, PMID: 36077630, PMCID: PMC9454847, doi: 10.3390/cancers14174092
Munoz et al, Immune modulation by molecularly targeted photothermal ablation in a
mouse model of advanced hepatocellular carcinoma and cirrhosis, Scientific Reports,
2022 Aug 24;12(1):14449, PMID: 36002545, PMCID: PMC9402568, doi: 10.1038/s41598-022-15948-3
Warner et al, Investigating Useful Features for Overall Survival Prediction in Patients
with Low-Grade Glioma Using Histology Slides, Annual International Conference of the
IEEE Engineering in Medicine and Biology Society (EMBC), , PMID: 36085890, PMCID:
, DOI: 10.1109/EMBC48229.2022.9871027
Vo et al, The genetic heterogeneity and drug resistance mechanisms of relapsed refractory
multiple myeloma, Nature Communications, 2022 Jun 29;13(1):3750, PMID: 35768438, PMCID:
PMC9243087, doi: 10.1038/s41467-022-31430-0
Velez-Delgado et al, Extrinsic KRAS Signaling Shapes the Pancreatic Microenvironment
Through Fibroblast Reprogramming, Cell Mol Gastroenterol Hepatol, 2022;13(6):1673-1699,
PMID: 35245687, PMCID: PMC9046274, doi: 10.1016/j.jcmgh.2022.02.016
Panigrahi et al, Integrative Bayesian models using Post-selective inference: A case
study in radiogenomics, Biometrics, 44789, PMID: 35973786, PMCID: , DOI: 10.1111/biom.13740
Krishnan S, Barua S, Frankel T, Rao A, Towards the characterization of the tumor microenvironment
through dictionary learning-based interpretable classification of multiplexed immunofluorescence
images, Phys Med Biol, 2022 Dec 21;68(1), PMID: 36541756, PMCID: , doi: 10.1088/1361-6560/aca86a
Zhao Z, Fritsche L, Smith J, Bukherjee B, Lee S, The construction of cross-population
polygenic risk scores using transfer learning, Am J Hum Genetics, 2022 Nov 3;109(11):1998-2008,
PMID: 36240765, PMCID: PMC9674947, doi: 10.1016/j.ajhg.2022.09.010
Salvatore M, Purkayastha S, Ganapathi L, Bhattacharyya R, Kundu R, Zimmermann L, Ray
D, Hazra A, Kleinsasser M, Solomon S, Subbaraman R, Mukherjee B, Lessons from SARS-CoV-2
in India: A data-driven framework for pandemic resilience, Sci Adv, 2022 Jun 17;8(24):eabp8621,
PMID: 35714183, PMCID: PMC9205583, doi: 10.1126/sciadv.abp8621
Khoja et al, Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian
cancer association, Gynocol Oncol, 2022 Jan;164(1):195-201, PMID: 34776242, PMCID:
PMC9444325, doi: 10.1016/j.ygyno.2021.10.088
Chen et al, Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis
and Systematic Review, J Infect Dis, 2022 Apr 16;jiac136, PMID: 35429399, PMCID: PMC9047189,
doi: 10.1093/infdis/jiac136
Du et al, Optimal diagnostic test allocation strategy during the COVID-19 pandemic
and beyond, Stat Med , 2022 Jan 30;41(2):310-327, PMID: 34697824, PMCID: PMC8661762,
doi: 10.1002/sim.9238
Brieger et al, High Prediagnosis Inflammation-Related Risk Score Associated with Decreased
Ovarian Cancer Survival, Cancer Epidemiol Biomarkers Prev, 2022 Feb;31(2):443-452,
PMID: 34789471, PMCID: PMC9281656, doi: 10.1158/1055-9965.EPI-21-0977
Beesley L, Mukherjee B, Statistical inference for association studies using electronic
health records: handling both selection bias and outcome misclassification, Biometrics,
2022 Mar;78(1):214-226, PMID: 33179768, doi: 10.1111/biom.13400
Tsao et al, Depression, Anxiety, and Patterns of Mental Health Care Among Men With
Prostate Cancer Receiving Androgen Deprivation Therapy, Oncologist, 2022 Apr 5;27(4):314-322,
PMID: 35298660, PMCID: PMC8982372, doi: 10.1093/oncolo/oyab033
Apfelbaum A, Wu F, Wawkins A, Magnuson B, Jimenez J, Taylor S, Wrenn E, Waltner O,
Pfaltzgraff E, Song J, Hall C, Wellik D, Ljungman M, Furlan S, Ryan R, Sarthy J, Lawlor
E, EWS-FLI1 and HOXD13 control tumor cell plasticity in Ewing sarcoma, Clin Cancer
Res, 2022 Jun 2;clincanres.0384.2022-2-5 13:20:00.280, PMID: 35653119, PMCID: PMC9588607,
doi: 10.1158/1078-0432.CCR-22-0384
Wang et al, SurvMaximin: Robust federated approach to transporting survival risk prediction
models, Journal of Biomedical Informatics, 2022 Oct;134:104176, PMID: 36007785, PMCID:
PMC9707637, doi: 10.1016/j.jbi.2022.104176
, Surgical Management of Rhabdomyosarcoma of the Nasal Cavity and Paranasal Sinuses:
Analysis of Operative Indications, Settings, and Outcomes, J Neurol Surg B Skull Base,
, PMID: , PMCID: ,
Smith J, Bellile E, Ellsperman S, Heft-Neal M, Mann J, Birkeland A, Hoesli R, Swiecicki
P, Worden F, Schonewolf C, Shah J, Mierzwa M, Rosko A, Stucken C, Chinn S, Shuman
A, Casper K, Malloy K, Prince M, Wolf G, Thomas D, McHuhh J, Brenner J, SPector M,
Prognostic value of CD103+ tumor-infiltrating lymphocytes and programmed death ligand-1
(PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma, Oral
Oncol, 2022 Dec;135:106226, PMID: 36323071, PMCID: , doi: 10.1016/j.oraloncology.2022.106226
Banerjee et al, Phosphorylation of TRIP13 at Y56 induces radiation resistance but
sensitizes head and neck cancer to cetuximab, Mol Ther, 2022 Jan 5;30(1):468-484,
PMID: 34111559, PMCID: PMC8753291 , doi: 10.1016/j.ymthe.2021.06.009
Costa de Medeiros M, Liu M, Banerjee R, Bellile E, D'Silva N, Rossa C, Galanin mediates
tumor-induced immunosuppression in head and neck squamous cell carcinoma, Cell Oncol
(dordr), 2022 Apr;45(2):241-256, PMID: 35267186, PMCID: PMC9050779, doi: 10.1007/s13402-021-00631-y
Michmerhuizen et al, Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease
survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma
model, Oral Oncol, 2022 Mar;126:105770, PMID: 35172244, doi: 10.1016/j.oraloncology.2022.105770
Swiecicki et al, Randomized trial of laryngeal organ preservation evaluating two cycles
of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor,
Head Neck, 2022 Jul;44(7):1509-1519, PMID: 35416374, doi: 10.1002/hed.27043
Rappold P, Vuong L, Leibold J, Chakiryan N, Curry M, Kuo F, Sabio E, Jiang H, Nixon
B, Liu M, Berglund A, Silagy A, Mascareno E, Golkaram M, Marker M, Reising A, Savchenko
A, Millholland J, Chen Y, Russo P, Coleman J, Reznik E, Manley B, Ostrovnaya I, Makarov
V, DiNatale R, Blum K, Ma X, Chowell D, Li M, Solit D, Lowe S, Chan T, Motzer R, Voss
M, Hakimi A, A Targetable Myeloid Inflammatory State Governs Disease Recurrence in
Clear Cell Renal Cell Carcinoma, Cancer Discov, 2022 Jun 27;candisc.0925.2021, PMID:
35758895, doi: 10.1158/2159-8290
Wang M, Jiang H, Liu X, Wang X, Biophysics involved in the process of tumor immune
escape, iScience, 2022 Mar 19;25(4):104124, PMID: 35402878, PMCID: PMC8983385, doi:
10.1016/j.isci.2022.104124
Jiang H, Huang L, Xia Y, Nonparametric regression with right-censored covariate via
conditional density function, Stat Med , 2022 May 20;41(11):2025-2051, PMID: 35124839,
doi: 10.1002/sim.9343
Wu W, Taylor JMG, Brouwer A, Luo L, Kang J, Jiang H, He K, Scalable proximal methods
for cause-specific hazard modeling with time-varying coefficients, Lifetime Data Anal,
2022 Apr;28(2):194-218, PMID: 35092553, PMCID: PMC9201734, doi: 10.1007/s10985-021-09544-2
Schmitd L, Perez-Pacheco C, Bellile E, Wu W, Casper K, Mierza M, Rozek L, Wolf G,
Taylor JMG, D'Silva N, Spatial and Transcriptomic Analysis of Perineural Invasion
in Oral Cancer, Clin Cancer Res, 2022 May 26;clincanres.4543.2021, PMID: 35617517,
PMCID: PMC9560986, doi: 10.1158/1078-0432.CCR-21-4543
Chang et al, Impact of Nodal Metastases in HPV-negative Oropharyngeal Cancer, Cancer
Epidemiol Biomarkers Prev, 2022 May 17;cebp.0776.2021, PMID: 35579907, doi: 10.1158/1055-9965.EPI-21-0776
Getz et al, The association between inflammatory biomarkers and statin use among patients
with head and neck squamous cell carcinoma, Head Neck, 2022 Jun;44(6):1393-1403, PMID:
35338544, PMCID: PMC9088158 , doi: 10.1002/hed.27040
Li P, Taylor JMG, Boonstra P, Lawrence T, Schipper M, Utility based approach in individualized
optimal dose selection using machine learning methods, Stat Med , 2022 Jul 20;41(16):2957-2977,
PMID: 35343595, PMCID: PMC9233043, doi: 10.1002/sim.9396.
Chua et al, Myotubularin-related phosphatase 5 is a critical determinant of autophagy
in neurons, Curr Biol, 2022 Jun 20;32(12):2581-2595.e6, PMID: 35580604, PMCID: PMC9233098,
doi: 10.1016/j.cub.2022.04.053
Yi et al, KDM6A Regulates Cell Plasticity and Pancreatic Cancer Progression by Noncanonical
Activin Pathway, Cell Mol Gastroenterol Hepatol, 2022;13(2):643-667, PMID: 34583087,
PMCID: PMC8715196, doi: 10.1016/j.jcmgh.2021.09.014
Kidwell et al, Application of Bayesian methods to accelerate rare disease drug development:
scopes and hurdles, Orphanet J Rare Dis, 2022 May 7;17(1):186, PMID: 35526036, PMCID:
PMC9077995, doi: 10.1186/s13023-022-02342-5
Hwang M, Medley S, Shakeel F, Vanderwerff B, Zawistowski M, Kidwell K, Hertz D, Lack
of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients
with cancer, Support Care Cancer, 2022 Sep;30(9):7355-7363, PMID: 35606478, doi: 10.1007/s00520-022-07118-y
Novice et al, Identifying Barriers and Facilitators to Scalp Cooling Therapy Through
a National Survey of the Awareness, Practice Patterns, and Attitudes of Oncologists,
JCO Oncol Pract, 2022 Feb;18(2):e225-e234, PMID: 34529505, doi: 10.1200/OP.21.00273
Kurlander et al, Development of a multicomponent implementation strategy to reduce
upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy,
and protocol for a pragmatic multilevel randomized factorial pilot implementation
trial, Implement Sci Commun, 2022 Jan 28;3(1):8, PMID: 35090577, PMCID: PMC8796614,
doi: 10.1186/s43058-022-00256-8
Acs et al, Systematically higher Ki67 scores on core biopsy samples compared to corresponding
resection specimen in breast cancer: a multi-operator and multi-institutional study,
Mod Pathol, 2022 Oct;35(10):1362-1369, PMID: 35729220, PMCID: PMC9514990, doi: 10.1038/s41379-022-01104-9
Pasternak et al, Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and
Conversions to Oral Therapy, Transplant Cell Therapy, 2022 Jan;28(1):19.e1-19.e7,
PMID: 34583027, doi: 10.1016/j.jtct.2021.09.011
Joyce et al, Association between nociplastic pain and premature endocrine therapy
discontinuation in breast cancer patients, Breast Cancer Research and Treatment, 44878,
PMID: 36371776, PMCID: , doi: 10.1007/s10549-022-06806-x
Hertz et al, Genome-wide association study of aromatase inhibitor discontinuation
due to musculoskeletal symptoms, Support Care Cancer, 2022 Oct;30(10):8059-8067, PMID:
35776183, PMCID: PMC9529953, doi: 10.1007/s00520-022-07243-8
Gonzalez et al, EZH2 T367 phosphorylation activates p38 signaling through lysine methylation
to promote breast cancer progression, iScience, 2022 Aug 2;25(8):104827., PMID: 35992062,
PMCID: PMC9389258, doi: 10.1016/j.isci.2022.104827.
Chao Y, Tran Q, Tsodikov A, Kidwell K, Joint modeling and multiple comparisons with
the best of data from a SMART with survival outcomes, Biostatistics, 2022 Jan 13;23(1):294-313,
PMID: 32659784, doi: 10.1093/biostatistics/kxaa025
Chao et al, Power prior models for estimating response rates in a small n, sequential,
multiple assignment, randomized trial, Statistical Methods in Medical Research, 2022
Dec;31(12):2297-2309, PMID: 36082955, PMCID: , doi: 10.1177/09622802221122795
Drake C, Kalmbach D, Cheng P, Ahmedani B, Peterson E, Joseph C, Roth T, Kidwell K,
Sagong C, Sleep to Reduce Incident Depression Effectively (STRIDE): study protocol
for a randomized controlled trial comparing stepped-care cognitive-behavioral therapy
for insomnia versus sleep education control to prevent major depression, Trials, 2022
Dec 1;23(1):967, PMID: 36457045, PMCID: PMC9713737,
Subbiah I, Markham M, Graff S, Matt-Amaral L, Close J, Griffith K, Jagsi R, Incidence,
Nature, and Consequences of Oncologists' Experiences With Sexual Harassment, J Clin
Oncol, 2022 Apr 10;40(11):1186-1195, PMID: 35089804, PMCID: PMC8987225, doi: 10.1200/JCO.21.02574.
Jagsi R, Griffith K, Vicini F, Boike T, Dominello M, Gustafson G, Hayman J, Moran
J, Radawski J, Walker E, Pierce L, Identifying Patients Whose Symptoms Are Underrecognized
During Treatment With Breast Radiotherapy, JAMA Oncology, 2022 Jun 1;8(6):887-894,
PMID: 35446337, PMCID: PMC9026246 , doi: 10.1001/jamaoncol.2022.0114
Jagsi R, Griffith K, Moran J, Vicini F, Pierce L, In Reply to Ling and Beriwal, Int
J Radiat Oncol Biol Phys, 2022 Mar 15;112(4):1064, PMID: 35190050, doi: 10.1016/j.ijrobp.2021.11.018
Singer K, Burns C, Griffith K, Opipari V, Martin D, Shellhaas R, Jagsi R, Gender Differences
in Endowed Chairs in Pediatrics, J Pediatr, 2022 May 27;S0022-3476(22)00492-9, PMID:
35636563, doi: 10.1016/j.jpeds.2022.05.040
Jones et al, Patient Experiences, Trust, and Preferences for Health Data Sharing,
JCO Oncol Pract, 2022 Mar;18(3):e339-e350, PMID: 34855514, PMCID: PMC8932496 , doi:
10.1200/OP.21.00491
Mody et al, Gender Differences in Work-Family Conflict Experiences of Faculty in Academic
Medicine, J Gen Intern Med, 2022 Jan;37(1):280-282, PMID: 33469767, PMCID: PMC8739409 ,
doi: 10.1007/s11606-020-06559-7
Jia et al, Factors Associated With Endowed Chair Allocation in Medical Oncology in
the United States, JNCI Cancer Spectr, 2022 May 2;6(3):pkac036, PMID: 35657340, PMCID:
PMC9165554, doi: 10.1093/jncics/pkac036
Gharzai L, Griffith K, Beeler W, Burrows H, Hammoud M, Rodgers P, Sabel M, Caethers
J, Jagsi R, Speaker Introductions at Grand Rounds: Differences in Formality of Address
by Gender and Specialty, J Women's Health (Larchmont), 2022 Feb;31(2):202-209, PMID:
34197213, doi: 10.1089/jwh.2021.0031
McClelland S, Huang C, Griffith K, Shan M, Holliday E, Jagsi R, Zellars R, Composition
of the Current Academic Radiation Oncology Workforce in Comprehensive Cancer Centers,
JCO Oncol Pract, 2022 May;18(5):e740-e747, PMID: 34919411, doi: 10.1200/OP.21.00609
Jagsi et al, Disease Control After Hypofractionation Versus Conventional Fractionation
for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational
Cohort, Int J Radiat Oncol Biol Phys, 2022 Mar 15;112(4):853-860, PMID: 34718094,
PMCID: PMC9020566 , doi: 10.1016/j.ijrobp.2021.10.012
Jagsi et al, Comparative Effectiveness Analysis of 3D-Conformal Radiation Therapy
Versus Intensity Modulated Radiation Therapy (IMRT) in a Prospective Multicenter Cohort
of Patients With Breast Cancer, Int J Radiat Oncol Biol Phys, 2022 Mar 1;112(3):643-653,
PMID: 34634437, doi: 10.1016/j.ijrobp.2021.09.053
Dilworth et al, The Impact of Chemotherapy on Toxic Effects and Cosmetic Outcome in
Patients Receiving Whole Breast Irradiation: An Analysis Within a Statewide Quality
Consortium, Int J Radiat Oncol Biol Phys, 2022 Jun 1;113(2):266-277, PMID: 35157997,
doi: 10.1016/j.ijrobp.2022.02.004
Jagsi R, Griffith K, Underrecognition of Symptoms During Breast Radiotherapy-Reply,
JAMA Oncology, 2022 Oct 1;8(10):1510-1511, PMID: 35951335, PMCID: , doi: 10.1001/jamaoncol.2022.3245
Coffman L, Orellana T, Liu T, Frisbie L, Normolle D, Griffith K, uppal S, McLean K,
Berger J, Boisen M, Courtney-Brooks M, Edwards R, Lesnock J, Mahdi H, Olawaiye A,
Sukumvanich P, Taylor S, Buckanovich R, Phase I trial of ribociclib with platinum
chemotherapy in ovarian cancer, JCI Insight, 2022 Sep 22;7(18):e160573, PMID: 35972817,
PMCID: PMC9675476, doi: 10.1172/jci.insight.160573
Champan C, Jagsi R, Griffith K, Moran J, Vicini F, Walker E, Dominello M, Abu-Isa
E, Hayman J, Laucis A, Mietzel M, Pierce L, Mediators of Racial Disparities in Heart
Dose Among Whole Breast Radiotherapy Patients, J Natl Cancer Inst, 2022 Dec 8;114(12):1646-1655,
PMID: 35916737, PMCID: , doi: 10.1093/jnci/djac120
Sahai V, Griffith K, Beg M, Shaib W, Mahalingam D, Zhen D, Deming D, Zalupski M, A
randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and
ipilimumab in previously untreated advanced biliary cancer: BilT-01, Cancer, 2022
Oct 1;128(19):3523-3530, PMID: 35895381, PMCID: PMC9540241, doi: 10.1002/cncr.34394
King R, Schaefer J, Sahai V, Griffith K, Sood S, Retrospective Cohort Analysis of
Aspirin Use and Venous Thromboembolism in Patients with Pancreatic Cancer and an Indwelling
Central Venous Catheter, TH Open, 2022 Aug 4;6(3):e221-e229, PMID: 36046199, PMCID:
PMC9352440, doi: 10.1055/s-0042-1747685
Shen C, Risk M, Schiopu E, Hayek S, Xie T, Holevinski L, Akin C, Freed G, Zhao L,
Efficacy of COVID-19 vaccines in patients taking immunosuppressants, Ann Rheum Dis,
2022 Jun;81(6):875-880, PMID: 35197265, PMCID: PMC9422955, doi: 10.1136/annrheumdis-2021-222045
Zhou K, Xia Y, Yang M, Xiao W, Zhao L, Hu R, Shoaib K, Yan R, Dai K, Actin polymerization
regulates glycoprotein Ibα shedding, Platelets, 2022 Apr 3;33(3):381-389, PMID: 33979555,
doi: 10.1080/09537104.2021.1922882
Liu et al, Carbodiphosphorane-Stabilized Parent Dioxophosphorane: A Valuable Synthetic
HO 2 P Source, J Am Chem Soc, 2022 Apr 27;144(16):7357-7365, PMID: 35436104, doi:
10.1021/jacs.2c00936
Dong T, Fan W, Tao Y, Wu R, Wang L, Zhao L, Liu L, Fan Z, Duodenal obstruction associated
with a ruptured pancreaticoduodenal artery aneurysm, Rev Esp Enferm Dig, 2022 Jul;114(7):438-439,
PMID: 35199535, doi: 10.17235/reed.2022.8727/2022
He et al, Prognostic Value of Histidine-Rich Glycoprotein for Community-Acquired Pneumonia,
Dis Markers, 2022 Feb 1;2022:4713045, PMID: 35154511, PMCID: PMC8824745, doi: 10.1155/2022/4713045
Zhang et al, TRX2/Rab35 Interaction Impairs Exosome Secretion by Inducing Rab35 Degradation,
Int J Mol Sci, 2022 Jun 12;23(12):6557, PMID: 35743001, PMCID: PMC9224307, doi: 10.3390/ijms23126557
Risk et al, Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant,
Clin Infect Dis, 2022 Feb 7;ciac106, PMID: 35137006, PMCID: PMC9047165, doi: 10.1093/cid/ciac106
Chen et al, Detection of Barrett's neoplasia with a near-infrared fluorescent heterodimeric
peptide, Endoscopy, 2022 Mar 17., PMID: 35299273, doi: 10.1055/a-1801-2406
Liu Y, Zhou S, Zhao L Gu X, Identification of Neuronal Cells in Sciatic Nerves of
Adult Rats, Front Cell Neuroscience, 2022 Mar 25;16:816814, PMID: 35401123, PMCID:
PMC8991689, doi: 10.3389/fncel.2022.816814.
Xing et al, Characteristics of peripheral blood Gamma-glutamyl transferase in different
liver diseases, Medicine (Baltimore), 2022 Jan 7;101(1):e28443, PMID: 35029891, PMCID:
PMC8735790, doi: 10.1097/MD.0000000000028443
Song et al, Identification and validation of prognosis-associated DNA repair gene
signatures in colorectal cancer, Sci Rep, 2022 Apr 28;12(1):6946, PMID: 35484177,
PMCID: PMC9050689, doi: 10.1038/s41598-022-10561-w
Wei et al, Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro
and in vivo by targeting PAK4, Br J Cancer, 2022 Apr;126(7):1037-1046, PMID: 34912075,
PMCID: PMC8980085, doi: 10.1038/s41416-021-01651-z
Bryant et al, De-escalating adjuvant durvalumab treatment duration in stage III non-small
cell lung cancer, Eur J Cancer, 2022 Jun 12;171:55-63, PMID: 35704975, doi: 10.1016/j.ejca.2022.04.033
Han et al, BCAP31 is involved in modulating colorectal cancer cell proliferation via
the Emerin/β-catenin axis, Exp Cell Res, 2022 Jun 15;418(1):113265, PMID: 35716785,
doi: 10.1016/j.yexcr.2022.113265
Bao et al, Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and
metastasis by targeting aurora kinase A, Cell Death Dis, 2022 Feb 25;13(2):189, PMID:
35217647, PMCID: PMC8881465, doi: 10.1038/s41419-022-04642-x
Taylor A, Setia N, Alpert L, Zhao L, Lamps L, Hart J, Waxman I, Hissong E, Choi E,
Shi J, Owens S, Westerhoff M, Measuring the Submucosal Depth of Invasion in Endoscopic
Mucosal Resections for Barrett-associated Adenocarcinoma, Arch Pathol Lab Med, 2022
Nov 1;146(11):1338-1344, PMID: 35213893, PMCID: PMC9402809, doi: 10.5858/arpa.2021-0072-OA
Worlikar et al, Impact of Histotripsy on Development of Intrahepatic Metastases in
a Rodent Liver Tumor Model, Cancers (Basel), 2022 Mar 22;14(7):1612, PMID: 35406383,
PMCID: PMC8996987, doi: 10.3390/cancers14071612
Bryant et al, Prognostic and predictive value of neutrophil-to-lymphocyte ratio with
adjuvant immunotherapy in stage III non-small-cell lung cancer, Lung Cancer, 2022
Jan;163:35-41, PMID: 34896803, PMCID: PMC8770596 , doi: 10.1016/j.lungcan.2021.11.021
Zhang et al, Long Non-Coding LEF1-AS1 Sponge miR-5100 Regulates Apoptosis and Autophagy
in Gastric Cancer Cells via the miR-5100/DEK/AMPK-mTOR Axis, Int J Mol Sci, 2022 Apr
26;23(9):4787, PMID: 35563178, PMCID: PMC9101949, doi: 10.3390/ijms23094787
Bryant et al, Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes
in Stage III Non-small Cell Lung Cancer, Int J Radiat Oncol Biol Phys, 2022 May 1;113(1):60-65.,
PMID: 35115216, PMCID: PMC9018488 , doi: 10.1016/j.ijrobp.2021.12.176
Deng et al, Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced
Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal
Microbiota, Nutrients, 2022 Feb 9;14(4):726, PMID: 35215376, PMCID: PMC8879943, doi:
10.3390/nu14040726
Taylor et al, Cribriform colon cancer: a morphological growth pattern associated with
extramural venous invasion, nodal metastases and microsatellite stability, J Clin
Pathol, 2022 Jul;75(7):483-487, PMID: 33782192, doi: 10.1136/jclinpath-2021-207485
Yousif et al, Quantitative Image Analysis as an Adjunct to Manual Scoring of ER, PgR,
and HER2 in Invasive Breast Carcinoma, Am J Clin Pathol, 2022 Jun 7;157(6):899-907,
PMID: 34875014, doi: 10.1093/ajcp/aqab206
Jiang C, Zhao L, Schuetze S, Chugh R, Giant Cell Tumor of Bone: Effect of Longer Dosing
Intervals of Denosumab on Tumor Control and Bone-related Complications, Oncologist,
2022 Jul 5;27(7):595-599, PMID: 35589095, PMCID: PMC9256029, doi: 10.1093/oncolo/oyac066
Sankar et al, Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance
in Veterans with Stage III Non-Small Cell Lung Cancer, Cancers (Basel), 2022 Jan
26;14(3):614., PMID: 35158881, PMCID: PMC8833364, doi: 10.3390/cancers14030614
Deng et al, SND1 acts as a functional target of miR-330-5p involved in modulating
the proliferation, apoptosis and invasion of colorectal cancer cells, Biochem Biophys
Res Commun, 2022 Jul 30;615:116-122, PMID: 35609416, doi: 10.1016/j.bbrc.2022.05.045
Song et al, Identification of an Endoplasmic Reticulum Stress-Related Gene Signature
to Evaluate the Immune Status and Pre, Front Genet, 2022 May 27;13:850200, PMID: 35711939,
PMCID: PMC9197218, doi: 10.3389/fgene.2022.850200
Bryant A, Sankar K, Strohbehn G, Zhao L, Daniel V, Elliott D, Ramnath N, Green M,
Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung
Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab, Int J Radiat
Oncol Biol Phys, 2022 Apr 18;S0360-3016(22)00248-6, PMID: 35450753, PMCID: PMC9246927,
doi: 10.1016/j.ijrobp.2022.03.015
Wages N, Braun T, Normolle D, Schipper M, Adaptive Phase 1 Design in Radiation Therapy
Trials, Int J Radiat Oncol Biol Phys, 2022 Jul 1;113(3):493-499, PMID: 35777394, PMCID:
PMC9260906, doi: 10.1016/j.ijrobp.2022.02.031
Jackson W, Tang M, Schipper M, Sandler H, Zumsteg Z, Efstathiou J, Shipley W, Seiferheld
W, Lukka H, Bahary JP, Zietman A, Pisansky T, Zeitzer K, Hall W, Dess R, Lovett R,
Balogh A, Feng F, Spratt D, Biochemical Failure Is Not a Surrogate End Point for Overall
Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601, J Clin
Oncol, 2022 Jun 23;JCO2102741, PMID: 35737923, PMCID: PMC9514834, doi: 10.1200/JCO.21.02741
Homer V, Yap C, Bond S, Holmes J, Stocken D, Walker K, Robinson E, Wheeler G, Brown
S, Hinsley S, Schipper M, Weir C, Rantell K, Prior T, Yu L, Kirkpatrick J, Bedding
A, Gamble C, Gaunt P, Early phase clinical trials extension to guidelines for the
content of statistical analysis plans, BMJ, 2022 Feb 7;376:e068177, PMID: 35131744,
PMCID: PMC8819597, doi: 10.1136/bmj-2021-068177
Cousins et al, Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and
Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90 Y Radioembolization:
Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity,
J Nucl Medicine, 2022 Jun;63(6):882-889, PMID: 34503962, PMCID: PMC9157720, doi: 10.2967/jnumed.121.262447
Chase E, Bryant A, Sun Y, Jackson W, Spratt D, Dess R, Schipper M, Development and
validation of a life expectancy calculator for US patients with prostate cancer, BJU
Int, 2022 Oct;130(4):496-506, PMID: 35373440, PMCID: PMC9474626, doi: 10.1111/bju.15740
Bryant et al, Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy
for Stage III Nonsmall-cell Lung Cancer, Am J Clin Onc, 2022 Apr 1;45(4):142-145,
PMID: 35271524, doi: 10.1097/COC.0000000000000899
Laucis et al, Racial Differences in Treatments and Toxicity in Patients With Non-Small-Cell
Lung Cancer Treated With Thoracic Radiation Therapy, JCO Oncol Pract, 2022 Jun;18(6):e1034-e1044,
PMID: 35167337, doi: 10.1200/OP.21.00224
Speers et al, Cardiac Magnetic Resonance Imaging and Blood Biomarkers for Evaluation
of Radiation-Induced Cardiotoxicity in Patients With Breast Cancer: Results of a Phase
2 Clinical Trial, Int J Radiat Oncol Biol Phys, 2022 Feb 1;112(2):417-425, PMID: 34509552,
doi: 10.1016/j.ijrobp.2021.08.039
Wilkie et al, Association Between Physician- and Patient-Reported Symptoms in Patients
Treated With Definitive Radiation Therapy for Locally Advanced Lung Cancer in a Statewide
Consortium, Int J Radiat Oncol Biol Phys, 2022 Mar 15;112(4):942-950, PMID: 34838865,
doi: 10.1016/j.ijrobp.2021.11.024
Owen et al, Investigating the Incidence of Pulmonary Abnormalities as Identified by
Parametric Response Mapping in Patients With Lung Cancer Before Radiation Treatment,
Adv Radiation Oncology, 2022 Apr 25;7(4):100980, PMID: 35693252, PMCID: PMC9184868,
doi: 10.1016/j.adro.2022.100980
Herr et al, Effect of Education and Standardization of Cardiac Dose Constraints on
Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across
a Statewide Consortium, Pract Radia Oncol, 2022 Feb 1;S1879-8500(22)00007-8, PMID:
35121192, doi: 10.1016/j.prro.2022.01.002.
Polan D, Epelman M, Wu V, Sun Y, Varsta M, Owen D, Jarema D, Matrosic C, Jolly S,
Schonewolf C, Schipper M, Matuszak M, Direct incorporation of patient-specific efficacy
and toxicity estimates in radiation therapy plan optimization, Med Phys, 2022 Oct;49(10):6279-6292,
PMID: 35994026PMC9826508, doi: 10.1002/mp.15940. Epub 2022 Sep 2
Covert E, Kitzpatrick K, Mikell J, Kaza R, Millet J, Barkmeier D, Gemmete J, Christensen
J, Schipper M, Dewaraja Y, Intra- and inter-operator variability in MRI-based manual
segmentation of HCC lesions and its impact on dosimetry, EJNMMI Phys, 2022 Dec 21;9(1):90,
PMID: 36542239PMC9772368, doi: 10.1186/s40658-022-00515-6
Cher B, Dykstra M, Wang C, Schipper M, Hayman J, Mayo C, Jagsi R, Trends in Radiation
Oncology Treatment Fractionation at a Single Academic Center, 2010 to 2020, Adv Radiation
Oncology, 2022 Jul 22;7(6):101032, PMID: 36072755PMC9441303, doi: 10.1016/j.adro.2022.101032
Cousins M, VanTil M, Steppe E, Ng S, Ellimoottil C, Sun Y, Schipper M, Evans J, Age,
race, insurance type, and digital divide index are associated with video visit completion
for patients seen for oncologic care in a large hospital system during the COVID-19
pandemic, PLoS One, 2022 Nov 17;17(11):e0277617, PMID: 36395112PMC9671352, doi: 10.1371/journal.pone.0277617
Mierzwa M, Aryal M, Lee C, Schipper M, VanTil M, Morales K, Swiecicki P, Casper K,
Malloy K, Spector M, SHuman A, Chinn S, Prince M, Stucken C, Rosko A, Lawrence T,
Brenner J, Rosen B, Schonewolf C, Shah J, Eisbruch A, Worden F, Cao Y, Randomized
Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis
Head and Neck Cancer, Clin Cancer REs, 2022 Dec 1;28(23):5049-5057, PMID: 36107219PMC9773159,
doi: 10.1158/1078-0432.CCR-22-1522
Jagsi R, Griffith K, Vicini F, Boike T, Dominello M, Gustafson G, Hayman J, Moran
J, Radawski J, Walker E, Pierce L, Identifying Patients Whose Symptoms Are Underrecognized
During Treatment With Breast Radiotherapy, JAMA Oncology, 2022 Jun 1;8(6):887-894,
PMID: 35446337PMC9026246, 2022 Jun 1;8(6):887-894
Vince R, Jiang R, Qi J, Tosoian J, Takele R, Feng F, Linsell S, Johnson A, Shetty
S, Hurley P, Miller D, George A, Ghani K, Sun F, Seymore M, Dess R, Jackson W, Schipper
M, Spratt D, Morgan T, Impact of Decipher Biopsy testing on clinical outcomes in localized
prostate cancer in a prospective statewide collaborative, Prostate Cancer Prostatic
Dis, 2022 Apr;25(4):677-683, PMID: 34285350PMC8770695, doi: 10.1038/s41391-021-00428-y
Jagsi R, Schipper M, Mietzel M, Pandya R, Moran J, Matuszak M, Vicini F, Jolly J,
Paximadis P, Mancini B, Griffith K, Hayman J, Pierce L, The Michigan Radiation Oncology
Quality Consortium: A Novel Initiative to Improve the Quality of Radiation Oncology
Care, Int J Radiat Oncol Biol Phys, 2022 Jun 1;113(2):257-265, PMID: 35124133, doi:
10.1016/j.ijrobp.2022.01.048
Hinton et al, Improved prediction of radiation pneumonitis by combining biological
and radiobiological parameters using a data-driven Bayesian network analysis, Trans
Oncol, 2022 Jul;21:101428, PMID: 35460942, PMCID: PMC9046881, doi: 10.1016/j.tranon.2022.101428
Qin et al, ATRX loss in glioma results in dysregulation of cell-cycle phase transition
and ATM inhibitor radio-sensitization, Cell Rep, 2022 Jan 11;38(2):110216, PMID: 35021084,
PMCID: PMC8759735, doi: 10.1016/j.celrep.2021.110216
Qin et al, Comprehensive enhancer-target gene assignments improve gene set level interpretation
of genome-wide regulatory data, Genome Biol, 2022 Apr 26;23(1):105, PMID: 35473573,
PMCID: PMC9044877, doi: 10.1186/s13059-022-02668-0
Van Poznak et al, Osteonecrosis of the jaw risk factors in bisphosphonate-treated
patients with metastatic cancer, Oral Dis, 2022 Jan;28(1):193-201, PMID: 33274559,
PMCID: PMC8284838 , doi: 10.1111/odi.13746
Chen D, Rob F, Mukherjee R, Girodano T, Haymart M, Banerjee M, Variation in the Diagnosis
of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features, J
Clin Endocrinol Metab, 2022 Sep 28;107(10):e4072-e4077, PMID: 35918064, PMCID: PMC9516041,
doi: 10.1210/clinem/dgac466
Koshkin et al, Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis
from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE)
study, Cancer, 2022 Mar 15;128(6):1194-1205, PMID: 34882781, doi: 10.1002/cncr.34057
Lussiez et al, A multi-modal study examining long-term bowel, urinary, and sexual
function after rectal cancer surgery, Am J Surg, 2022 Jul;224(1 Pt B):562-568, PMID:
35260231, doi: 10.1016/j.amjsurg.2022.02.046
Radhakrishnan et al, Physician Specialties Involved in Thyroid Cancer Diagnosis and
Treatment: Implications for Improving Health Care Disparities, J Clin Endocrinol Metab,
2022 Feb 17;107(3):e1096-e1105, PMID: 34718629, PMCID: PMC8852205 , doi: 10.1210/clinem/dgab781
Radhakrishnan et al, Exploring Variation in the Receipt of Recommended Active Surveillance
for Men with Favorable-Risk Prostate Cancer, J Urol, 2022 May 6;101097JU0000000000002734,
PMID: 35522191, PMCID: PMC9378546, doi: 10.1097/JU.0000000000002734
Berlin et al, Perceived financial decline related to breast reconstruction following
mastectomy in a diverse population-based cohort, Cancer , 2022 Mar 15;128(6):1284-1293,
PMID: 34847259, PMCID: PMC8882150 , doi: 10.1002/cncr.34048.
Kurian et al, Chemotherapy Regimens Received by Women with BRCA1/2 Pathogenic Variants
for Early-Stage Breast Cancer Treatment, JNCI Cancer Spectr, 2022 Jun 20;pkac045,
PMID: 35723570, PMCID: PMC9305849, doi: 10.1093/jncics/pkac045
Suwanabol P, Li Y, Abrahamse P, Roo A, Vu J, Milveira M, Mody L, Dimick J, Functional
and Cognitive Decline Among Older Adults After High-risk Surgery, Ann Surg, 2022 Jan
1;275(1):e132-e139, PMID: 32404660, PMCID: PMC8060894 , doi: 10.1097/SLA.0000000000003950
Veensta C, Ellis K, Abrahamse P, Ward K, Morris A, Hawley S, A dyadic survey study
of partner engagement in and patient receipt of guideline-recommended colorectal cancer
surveillance, BMC Cancer, 2022 Oct 13;22(1):1060., PMID: 36339796, PMCID: PMC9559022,
doi: 10.1186/s12885-022-10131-3
Kurian A, Abrahamse P, Bondarenko I, Hamilton A, Deapen D, Gomez S, Morrow M, Berek
J, Hofer T, Katz S, Ward K, Association of Genetic Testing Results With Mortality
Among Women With Breast Cancer or Ovarian Cancer, J Natl Cancer Inst, 2022 Feb 7;114(2):245-253,
PMID: 34373918, PMCID: PMC8826508 , doi: 10.1093/jnci/djab151
Veenstra C, Braun T, Abrahamse P, Wittman D, Hawley S, Employment outcomes in family
supporters of patients with early stage breast cancer and their association with patients'
health-related quality of life and financial burden, Cancer Med, 2022 Mar;11(5):1324-1335,
PMID: 35112499, PMCID: PMC8894687, doi: 10.1002/cam4.4513
Kohne J, MacLaren G, Cagino L, Boonstra P, Brodie D, Barbaro R, Tracheostomy Practices
and Outcomes in Patients With COVID-19 Supported by Extracorporeal Membrane Oxygenation:
An Analysis of the Extracorporeal Life Support Organization Registry, Crit Care Med,
2022 Sep 1;50(9):1360-1370, PMID: 35607973, PMCID: PMC9380152, doi: 10.1097/CCM.0000000000005579
Li et al, Utility based approach in individualized optimal dose selection using machine
learning methods, Statistics in Medicine, 2022 Jul 20;41(16):2957-2977, PMID: 35343595PMC9233043,
doi: 10.1002/sim.9396
Abghari-Gerst et al, A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically
Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients,
Journal of Nuclear Medicine, 2022 Apr;63(4):567-572, PMID: 34326126PMC8973291, doi:
10.2967/jnumed.121.262412
Guo C, Kang J, Johnson T, A spatial Bayesian latent factor model for image-on-image
regression, Biometrics, 2022 Mar;78(1):72-84, PMID: 33368210PMC8236065, doi: 10.1111/biom.13420
Whiteman et al, Bayesian Inference for Brain Activity from Functional Magnetic Resonance
Imaging Collected at Two Spatial Resolutions, Annals of Applied Statistics, 2022 Dec;16(4):2626-2647,
PMID: 36338823PMC9629780, doi: 10.1214/22-aoas1606
Messinger et al, Therapeutic targeting of prenatal pontine ID1 signaling in diffuse
midline glioma, Neuro Oncol, 2022 May 23;noac141, PMID: 35605606, doi: 10.1093/neuonc/noac141
Frame et al, Defibrotide Therapy for SARS-CoV-2 ARDS, Chest, 2022 Apr 9;S0012-3692(22)00593-1,
PMID: 35413279, PMCID: PMC8993696, doi: 10.1016/j.chest.2022.03.046
Wittman et al, TrueNTH Sexual Recovery Intervention for couples coping with prostate
cancer: Randomized controlled trial results, Cancer, 2022 Apr 1;128(7):1513-1522,
PMID: 34985771, doi: 10.1002/cncr.34076
Braun T, Mercier F, Extending the Continual Reassessment Method to accommodate step-up
dosing in Phase I trials, Stat Med , 2022 Sep 10;41(20):3975-3990, PMID: 35662077,
PMCID: PMC9546169, doi: 10.1002/sim.9487
Raj M, Gupta V, Hoodin F, Clingan C, Roslin C, Yahng L, Braun T, Choi S, Evaluating
mobile Health technology use among cancer caregivers in the digital era, Digital Health,
2022 Jun 22;8:20552076221109071, PMID: 35769358, PMCID: PMC9234853, doi: 10.1177/20552076221109071
Qazilbash M, Saini N, Cha S, Wang Z, Stadtmauer E, Baladandayuthapani V, Lin H, Tross
B , Honhar M, Rao S, Kim K, Popescu M, Szymura S, Zhang T, Anderson A, Bashir Q, Shpall
E, Orlowski R, Levine B, Kerr N, Garfall A, Cohen A, Vogl D, Dengel K, June C, Champin
R, Kwak L, A randomized phase 2 trial of idiotype vaccination and adoptive autologous
T-cell transfer in patients with multiple myeloma, Blood, 2022 Mar 3;139(9):1289-1301,
PMID: 34521108, PMCID: PMC8900281 , doi: 10.1182/blood.2020008493
Tanaka I, Dayde D, Tai M, Mori H, Solis L, Tripahi S, Fahrmann J, Unver N, Parhy G,
Jain R, Parra E, Murakami Y, Aguilar-Bonavides C, Mino B., Celiktas M, Shillon D,
Casabar J, Nakatochi M, Stingo F, Baladandayuthapani V et al, SRGN-Triggered Aggressive
and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas,
J Natl Cancer Inst, 2022 Feb 7;114(2):290-301, PMID: 34524427, PMCID: PMC8826620 ,
doi: 10.1093/jnci/djab183
Ni Y, Baladandayuthapani V, Vannucci M, Stingo F, Bayesian graphical models for modern
biological applications, Stat Methods Appt, 2022;31(2):197-225, PMID: 35673326, PMCID:
PMC9165295, doi: 10.1007/s10260-021-00572-8
Ma V, Perera C, Sun Y, Sitto M, Waninger J, Warrier G, Green M, Fecher L, Lao C, Early
Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab,
Front Immunology, 2022 Jul 6;13:860421, PMID: 35874737, PMCID: PMC9296775, doi: 10.3389/fimmu.2022.860421
Hirschtick J, Cook S, Patel A, Barnes G, Arenberg D, Bondarenko I, Levy D, Jeon J,
Medoza E, Meza R, Fleischer N, Longitudinal associations between exclusive and dual
use of electronic nicotine delivery systems and cigarettes and self-reported incident
diagnosed cardiovascular disease among adults, Nicotine Tob Res, 2022 Jul 30;ntac182,
PMID: 35907264, PMCID: , 2022 Jul 30;ntac182
Li G, Xu S, Yang S, Wu C, Zhang L, Wang H, An immune infiltration-related long non-coding
RNAs signature predicts prognosis for hepatocellular carcinoma, Front Genet, 2022
Dec 8;13:1029576, PMID: 36568382, PMCID: PMC9773198, doi: 10.3389/fgene.2022.1029576
Ma L, Li G, Yang T, Zhang L, Wang X, Xu X, Hi H, An inhibitor of BRD4, GNE987, inhibits
the growth of glioblastoma cells by targeting C-Myc and S100A16, Cancer Chemother
Pharmacol, 2022 Dec;90(6):431-444, PMID: 36224471, PMCID: PMC9637061, doi: 10.1007/s00280-022-04483-7
Lee J, Wang N, Turk S, Mohammed S, Lobo R, Kim J, Liao E, Camelo-Piragua S, Kim M,
Junck L, Bapuraj J, Srinivasan A, Rao A, Discriminating Pseudoprogression and True
Progression in Diffuse Infiltrating Glioma using Multi-parametric MRI data through
Deep Learning. Scientific Reports, 2020;10(1):20331, PMID: 33230285 Steele, N.G, et
al. Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancer.
Clinical Cancer Research (2020). (in press)
Caissie A, Mierzwa M, Fuller C et al. Radiotherapy (RT) Patterns Of Practice Variability
Identified As A Challenge To Real-World Big Data: Recommendations From The Learning
From Analysis Of Multicenter Big Data Aggregation (LAMBDA) Consortium. International
Journal of Radiation Oncology*Biology*Physics. 2020;108(3):e773-e774. doi:10.1016/j.ijrobp.2020.07.224
Steele N, Carpenter E, Kemp S et al. Multimodal mapping of the tumor and peripheral
blood immune landscape in human pancreatic cancer. Nat Cancer. 2020;1(11):1097-1112.
doi:10.1038/s43018-020-00121-4
Carpenter E, Steele N, Kemp S et al. S0002 Developing a Multimodal Platform for Precision
Medicine Using Endoscopic Fine Needle Biopsies in Pancreatic Cancer. American Journal
of Gastroenterology. 2020;115(1):S1-S1. doi:10.14309/01.ajg.0000697892.97250.42
Li T, Tripathi A, Yu F, Sherman D, Rao A. DDAP: docking domain affinity and biosynthetic
pathway prediction tool for type I polyketide synthases.Bioinformatics. 2019. doi:10.1093/bioinformatics/btz677
Mayo C, Mierzwa M, Moran J et al. Combination of a Big Data Analytics Resource System
With an Artificial Intelligence Algorithm to Identify Clinically Actionable Radiation
Dose Thresholds for Dysphagia in Head and Neck Patients. Adv Radiat Oncol. 2020;5(6):1296-1304.
doi:10.1016/j.adro.2019.12.007
Bankhead III A, McMaster T, Wang Y, Boonstra PS, Palmbos PL: “TP63 Isoform Expression is Linked
with Distinct Clinical Outcomes in Cancer” EBioMedicine 2020, 51, 10256.
Beeler WH, Bellile EL, Casper KA, Jaworski E, Burger NJ, Malloy KM, Spector ME, Shuman AG, Rosko A, Stucken
CL, Chinn SB, Dragovic AF, Chapman CH, Owen D, Jolly S, Bradford CR, Prince MEP, Worden
FP, Jagsi R, Mierzwa ML, Swiecicki PL: “Patient-reported financial toxicity and adverse
medical consequences in head and neck cancer”, Oral Oncol, 101:104521, doi: 10.1016/j.oraloncology.2019.104521,
Epub ahead of print, PMID: 31877502.
Caram MEV, Ross R, Lin P, Mukherjee B: “Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate
Cancer” JAMA Open Network, 2 (4), e192589-e192589. 2019.
Cheng, W, Taylor JMG, Gu T, Tomlins SA, Mukherjee B “Informing a Risk Prediction Model for Binary Outcomes with External Coefficient
Information” Journal of Royal Statistical Society, 2019 Jan, 68(1): 121-139. PMC6519970.
Das P, Peterson C, Do K, Akbana R, Baladandayuthapani V: "NExUS: Bayesian simultaneous network estimation across unequal sample sizes”, Bioinformatics,
btz636, 2019. https://doi.org/10.1093/bioinformatics/btz636
Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Schipper MJ*, Spratt DE*. *Contributed Equally: “Association of Black Race with Prostate Cancer-Specific
and Other-Cause Mortality” JAMA Oncology: 2019. PMC6547116.
Dewaraja YK, Devasia T, Kaza RK, Mikell JK, Owen D, Roberson PL and Schipper MJ: “Accurately predicting tumor control in 90Y radioembolization by logit models with
PET/CT based dose metrics” Journal Nuclear Medicine: 2019. PMC6954459.
Ettel M, Zhao L, Schechter S, Shi J; “Expression and prognostic value of NSD1 and SETD2 in pancreatic
ductal adenocarcinoma and its precursor lesions.” Pathology. 2019. PMC6544165.
Ferrer-Torres D, Nancarrow DJ, Steinberg H, Wang Z, Kuick R, Weh KM, Mills RE, Ray D, Ray P, Lin J, Chang AC, Reddy RM, Orringer MB, Canto MI,
Shaheen NJ, Kresty LA, Chak A, Wang TD, Rubenstein JH, Beer DG. “Constitutively Higher
Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against
DNA Damage” Gastroenterology. 2019 Apr;156(5):1404-1415.PMCID: PMC6441633.
Frydrych L, Ulintz P, Bankhead III A, Greenson J, Maguire L, Sifuentes CJ, Fearon E, Hardiman KM: “Rectal Cancer Sub-Clones
Respond Differentially to Neoadjuvant Therapy” Neoplasia 2019, 21(10):1051-1062.
Gates EDH, Lin JS, Weinberg JS, Hamilton J, Prabhu SS, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes D, Schellingerhout D: “Guiding the first biopsy in glioma patients using
estimated Ki-67 maps derived from MRI: conventional versus advanced imaging”, Neuro
Oncol, 2019, 21(4): 527-536.
Hawkins PG, Sun Y, Dess RT, Jackson WC, Sun G, Bi N, Tewari M, Hayman JA, Kalemkerian
GP, Gadgeel SM, Lawrence TS, Haken RKT, Matuszak MM, Kong FS, Schipper MJ, Jolly S: “Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity
in non-small-cell lung cancer.” J Cancer Res Clin Oncol: 2019. PMC6956699.
Kamdem LK, Xi J, Clark BL, Gregory BJ, Kidwell KM, Storniolo AM, Stearns V, Hayes DF, Gersch CL, Rae JM, Henry NL, Hertz DL; “Exemestane
may be less detrimental than letrozole to bone health in women homozygous for UGT2B17*2
gene deletion.” Breast Cancer Research and Treatment, 2019. PMC6534458.
Katz SJ, Bondarenko I, Ward KC.: “Association of attending surgeon with variation in the receipt of genetic
testing after diagnosis of breast cancer “(vol 153, pp 909, 2018). JAMA Surgery. ,154(3):
p.272, 2019.
Kim MM, Speers C, Li P, Schipper M, Junck L, Leung D, Orringer D, Heth J, Umemura Y, Spratt DE, Wahl DR, Cao Y, Lawrence
TS, Tsien CI: “Dose-intensified chemoradiation is associated with altered patterns
of failure and favorable survival in patients with newly diagnosed glioblastoma.”
J Neurooncol: 2019. PM30977058. [Epub ahead of print]
Kim RY, Helman JI, Braun TM, and Ward BB. “Does Perineural Invasion, a Negative Predictor of Outcome in Oral Squamous
Cell Carcinoma, Have Site-Specific Correlation?” Head & Neck (77): 852-858, 2019.
Kim S, Wang M, Tyrer JP, Jensen A, Wiensch A, Liu G, Lee AW, Ness RB, Mukherjee B: “A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome‐wide
significant common variants” International Journal of Cancer, 144 (9), 2192-2205.
2019.
Lee W, Miranda MF, Rausch P, Baladandayuthapani V, Fazio M, Downs JC, Morris JS: “Bayesian Semiparametric Functional Mixed Models for
Serially Correlated Functional Data, with Application to Glaucoma Data”, J AM Stat
Assoc, 2019, 114(526): 495-513.
Lu T, Bankhead III A, Ljungman M, Neamati N. “Multi-omics profiling reveals key signaling pathways in
ovarian cancer controlled by STAT3” Theranostics 2019; 9(19):5478-5496.
Luo X, Donnelly CR, Gong W, Heath BR, Hao Y, Donnelly LA, Moghbeli T, Tan YS, Lin
X, Bellile E, Kansy BA, Carey TE, Brenner JC, Cheng L, Polverini PJ, Morgan MA, Wen H, Prince ME,
Ferris RL, Xie Y, Young S, Wolf GT, Chen Q, Lei YL: “HPV16 drives cancer immune escape
via NLRX1-mediated degradation of STING”, J Clin Invest, Epub ahead of print, doi:
10.1172/JCI129497, PMID: 31874109.
Ma X, Kang X, He L, Zhou J, Zhou J, Sturm MB, Beer DG, Kuick RD, Nancarrow DJ, Appelman HD, Pang Z, Li W, Zhang C, Zhang W, Zhang Y, Wang TD, Li M.
“Identification of tumor specific peptide as EpCAM ligand and its potential diagnostic
and therapeutic clinical application” Mol Pharm. 2019 May 6;16(5):2199-2213. PMID:
30974945.
Maity AK, Bhattacharya A, Ballick BK, Baladandayuthapani V: “Bayesian data integration and variable selection for pan-cancer survival prediction
using protein expression data”, Biometrics, 2019, Epub ahead of print, PMID: 3139300.
Manasanch EE, Han G, Mathur R, Qing Y, Zhang Z, Lee H, Weber DM, Amini B, Berkova
Z, Eterovic K, Zhang S, Zhang J, Song X, Mao X, Morgan M, Feng L, Baladandayuthapani V, Futreal A, Wang L, Neelapu SS, Orlowski RZ: “A pilot study of pembrolizumab in smoldering
myeloma: report of the clinical, immune and genomic analysis”, Blood Adv, 2019, 3(15):
2400-2408.
Manton T, Tillman B, McHugh J, Bellile E, McLean S, McKean E. “Sinonasal Melanoma: A Single Institutional Analysis and Future
Directions” J Neurol Surg B Skull Base. 2019 Oct;80(5):484-492. doi: 10.1055/s-0038-1676355.
PMCID: PMC6748852.
Marisetty AL, Lu L, Veo BL, Liu B, Coarfa C, Kamal MM, Kassem DH, Irshad K, Lu Y,
Gumin J, Henry V, Paulucci-Holthauzen A, Rao G, Baladandayuthapani V, Lang FF, Fuller GN, Majumder S: ” REST-DRD2 mechanism impacts glioblastoma stem
cell-mediated tumorigenesis”, Neuro Oncol, 2019, 21(6): 775-785.
McCool K, Freeman ZT, Zhai Y, Wu R, Hu K, Liu CJ, Tomlins SA, Fearon ER, Magnuson B, Kuick R, Cho KR. “Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations,
Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts”
Cancer Res. 2019 Dec 5. doi: 10.1158/0008-5472.CAN-19-2558. [Epub ahead of print]
PMID:31806642.
Michmerhuizen NL, Leonard E, Matovina C, Harris M, Herbst G, Kulkarni A, Zhai J, Jiang H, Carey TE, Brenner JC, “Rationale for using irreversible EGFR Inhibitors in combination
with PI3K inhibitors for advanced Head and Neck Squamous Cell Carcinoma.” Molecular
Pharmacology, doi: 10.1124/mol.118.115162, 2019. PMC6442321.
Muenz D, Taylor JMG, Braun T: “Phase I/II Trial Design for Biologic Agents using CAR Models for Toxicity & Efficacy.”
Journal of the Royal Statistical Society, Series C (68): 331-345, 2019.
Nez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-Fabiani MB, Haase
S, Koschmann C, Calinescu AA, Kamran N, Saxena M, Patel R, Carney S, Guo MZ, Edwards
M, Ljungman M, Qin T, Sartor MA, Tagett R, Venneti S, BrosnanCashman J, Meeker A, Gorbunova V, Zhao L, Kremer DM, Zhang L, Lyssiotis CA, Jones L, Herting CJ, Ross JL, Hambardzumyan D,
Hervey-Jumper S, Figueroa ME, Lowenstein PR, Castro MG; “IDH1-R132H acts as a tumor
suppressor in glioma via epigenetic up-regulation of the DNA damage response.” Sci
Transl Med., 11(479). 2019.
Ni Y, Stingo FC, Ha MJ, Akbani R, Baladandayuthapani V: “Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer
Proteogenomics”, J Am Stat Assoc, 2019, 114(525): 48-60.
Palmbos P, Wang Y, Bankhead III A, Kelleher A, Wang L, Yang H, Ahmet M, Gumkowski E, Welling S, Magnuson B, Leflein J, Lorenzatti G, Abel E, Dziubinski M, Urs S, Day M, Ljungman M, Simeone
D, “ATDC mediates a TP63-regulated basal cancer invasive program” Oncogene, 1476-5594,
2019. PMC6290910.
Rozek L., Virani S., Bellile E., Taylor JMG, Sartor M., Zarins K., Virani A., Cote C., Worden F., Prince M., McLean S., Duffy
S., Yoo G., Saba N., Shin D., Kucuk O., Wolf G.T., “Soy Isoflavone Supplementation
Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and
Neck Squamous Cell Carcinoma”, Nutrition and Cancer, 71(5), 772-780, 2019.
Spector ME, Bellile E, Amlani L, Zarins K, Smith J, Brenner JC, Rozek L, Nguyen A, Thomas D, McHugh JB,
Taylor JMG, Wolf GT. “Prognostic Value of Tumor-Infiltrating Lymphocytes in Head and Neck Squamous
Cell Carcinoma” JAMA Otolaryngol Head Neck Surg. 2019 Sep 5;. doi: 10.1001/jamaoto.2019.2427.
Epub ahead of print. PMCID: PMC6735419.
Tang J, Feng Y, Kuick R, Green M, Green M, Sakamoto N, Kurosu Y, Lin J, Cho KR, Fearon ER. “Trp53 null and
R270H mutant alleles have comparable effects in regulating invasion, metastasis, and
gene expression in mouse colon tumorigenesis” Lab Invest. 2019 Oct;99(10):1454-1469.
Epub 2019 May 31. PMCID:PMC6759392.
Taylor JMG, Shuman AG, Beesley LJ, “Individualized prognostic calculators in the precision oncology
era” Oncotarget 10 (4), 415. 2019.
Veenstra C, Wallner L, Abrahamse P; Janz N, Katz S, Hawley S; “Understanding the engagement of key decision support
persons in patient decision making around breast cancer treatment.” Cancer, 2019.
PMC6486440.
Wallner L, Li Y, McLeod M, Gargaro J, Kurian A, Jagsi R, Radhakrishnan A, Hamilton A, Ward K, Hawley S, Katz
S. “Primary care provider–reported involvement in breast cancer treatment decisions.” Cancer,
2019, 125: 1815-1822. PMC6509002.
Wang Y, Kim TH, Fouladdel S, Zhang Z, Soni P, Qin A, Zhao L, Azizi E, Lawrence TS, Ramnath N, Cuneo KC, Nagrath S; “PD-L1 Expression in Circulating
Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small
Cell Lung Cancer.” Sci Rep., 9(1):566. 2019.
Wang Y, Sessine MS, Zhai Y, Tipton C, McCool K, Kuick R, Connolly DC, Fearon ER, Cho KR. “Lineage tracing suggests that ovarian endosalpingiosis
does not result from escape of oviductal epithelium” J Pathol. 2019 Oct;249(2):206-214.
Epub 2019 Jul 8. PMID:31131879.
Wang F, Duan X, Chen J, Gao Z, Zhou J, Wu X, Chang TS, Lee M, Li G, Nusrat A, Kuick R, Appelman HD, Wang TD. “Integrated Imaging Methodology Detects Claudin-1 Expression
in Premalignant Nonpolypoid and Polypoid Colonic Epithelium in Mice” Clin Transl Gastroenterol.
2020 Jan 9. doi: 10.14309/ctg.0000000000000089. [Epub ahead of print] PMID:31922993.
Wu X, Zhou J, Wang F, Meng X, Chen J, Chang TS, Lee M, Li G, Li X, Appelman HD, Kuick R, Wang TD. “Detection of colonic neoplasia in vivo using near-infrared-labeled peptide
targeting cMet” Sci Rep. 2019 Nov 29;9(1):17917. PMCID:PMC6884535.
Xu S, Liu Y, Yang K, Wang H, Shergalis A, Kyani A, Bankhead III A, Tamura S, Yang S, Wang X, Wang CC, Rehemtulla A, Ljungman M, Neamati N. “Inhibition
of protein disulfide isomerase in glioblastoma causes marked downregulation of DNA
repair and DNA damage response genes” Theranostics 2019; 9(8):2282-2298.
Zhou Q, Li H, Li Y, Tan M, Fan S, Cao C, Meng F, Zhu L, Zhao L, Guan MX, Jin H, Sun Y; “Inhibiting neddylation modification alters mitochondrial
morphology and reprograms energy metabolism in cancer cells.” JCI Insight, 4(4):121582.
2019.
Zick S, Sen A, Hassatt A, Schrepf A, Wyatt G, Murphy S, Arnedt J, Harris R; “Impact of Self-Acupressure
on Co-Occurring Symptoms in Cancer Survivors” JNCI Cancer Spectrum ; 2 (4); 2019.
Abel EV, Goto M, Magnuson B, Abraham S, Ramanathan N, Hotaling E, Alaniz AA, Kumar-Sinha
C, Dziubinski ML, Urs S, Wang L, Shi J, Waghray M, Ljungman M, Crawford HC, Simeone
DM. “HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties”.
2018. Elife. PMID: 3007447.
Altan M, Kidwell KM, Pelekanou V, Carvajal-Hausdorf DE, Schalper KA, Toki M, Thomas
DG, Sabel MS, Hayes DF, Rimm DL; “Associations of B7-H4, PD-L1 and tumor infiltrating
lymphocytes with outcomes in breast cancer.” NPJ Breast Cancer. Dec 10: 4:40, 2018.
Anwar T, Arellano-Garcia C, Ropa J, Chen Y, Kim H, Yoon E, Grigsby S, Basrur V, Nesvizhskii
A, Muntean A, Gonzalez M, Kidwell K, Nikolovska-Coleska Z, Kleer C; “p38-mediated
phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer
metastasis.” Nature Communications. 9(1):2801, 2018.
Banerjee M, Reyes-Gastelum D, Haymart MR. “Treatment-free Survival in Patients with
Differentiated Thyroid Cancer.” Journal of Clinical Endocrinology and Metabolism,
103:2720-2727, 2018. PMID: 29788217.
Beesley LJ, Morgan TM, Spratt DE, Singhal U, Feng FY, Furgal AC, Jackson WC, Daignault
S, Taylor JMG: “Individual and Population Comparisons of Surgery and Radiotherapy
Outcomes in Prostate Cancer Using Bayesian Multistate Models.”, JAMA Open Network,
2(2): e187765. 2018, PMC6484613.
Beesley LJ, Hawkins P, Amlani LH, Bellile E, Casper KA, Chinn SB, Eisbruch A, Mierzwa
ML, Spector ME, Wolf GT, Shuman AG, Taylor JMG: “Individualized Survival Prediction
for Patients with Oropharyngeal Cancer in the Human Papillomavirus Era” Cancer, 125(1):68-78,
2018. PMC6309492.
Bhave MA, Speth KA, Kidwell KM, Lyden A, Alsamarraie C, Murphy S, Henry NL; “Effect
of aromatase inhibitor therapy on sleep and activity patterns in early stage breast
cancer.” Clinical Breast Cancer. 18(2): 168-174, 2018.
Caram M, Wang S,Tsao P, Griggs JJ, Miller DC, Hollenbeck BK, Lin P, Mukherjee B: “Patient
and Provider Variables Associated with Variation in the Systemic Treatment of Advanced
Prostate Cancer” Urology Practice, 10.1097/UPJ. 0000000000000020. 2018.
Caram MEV, Estes JP, Griggs JJ, Lin P, Mukherjee B: “Temporal and geographic variation
in the systemic treatment of advanced prostate cancer” BMC cancer 18 (1), 258. 2018.
Castillo CG, Kauffman CA, Zhai J, Jiang H, Agozino SM, Miceli MH: “Testing the performance
of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis
of invasive pulmonary aspergillosis in high-risk patients.” Mycoses, 61(1):4-10, 2018,
PMID: 28905439.
Colacino JA, Azizi E, Brooks MD, Harouaka R, Fouladdel S, McDermott SP, Lee M, Hill
D, Madden J, Boerner J, Cote ML, Sartor MA, Rozek LS, Wicha MS: “Heterogeneity of
Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling.”
Stem Cell Reports, 10(5):1596-1609, 2018, PMC5995162.
Cuneo KC, Morgan MA, Griffith KA, Hawkins PG, Greenson JK, Ben-Josef E, Lawrence TS,
and Zalupski MM: “Prognostic Value of c-MET Expression in Patients with Pancreatic
Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy.” Int J Radiat Oncol
Biol Phys, 100(2):490-497, 2018, PMID: 29229329.
Davis EJ, Griffith KA, Kim EJ, Ruch JM, McDonnell KJ, and Zalupski MM: “A phase II
study of biweekly cisplatin, fixed dose rate gemcitabine and infusional 5-fluorouracil
in patients with metastatic pancreatic and biliary cancers.” Am J Clin Oncol, 41(2):128-132,
2018, PMC4854803.
Dess RT, Devasia TP, Aghdam N, Jackson WC, Soni PD, Smith CP, Mitchell AL, Suy S,
Hamstra DA, Jolly S, Nguyen PL, Feng FY, Schipper MJ, Skolarus TA, Miller DC, Wittmann
DA, Collins SP, Spratt DE: “Patient-Reported Sexual Aid Utilization and Efficacy After
Radiation Therapy for Localized Prostate Cancer.” Int J Radiat Oncol Biol Phys, 101(2):376-386,
2018, PMID: 29487023.
Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB,
Zumsteg ZS, Mehra R, Morgan TM, Feng FY, Hamstra DA, Schipper MJ, Collins SP, Spratt
DE: “Erectile Function after Stereotactic Body Radiotherapy for Prostate Cancer: Comparison
to Nerve-Sparing Prostatectomy and Conventional Radiotherapy.” BJU Int, 121(1):61-68,
2018, PMID: 28710895.
El Naqa I, Ruan D, Valdes G, Dekker A, McNutt T, Ge Y, Wu QJ, Oh JH, Thor M, Smith
W, Rao A, Fuller C, Xiao Y, Manion F, Schipper M, Mayo C, Moran JM, Ten Haken R: Machine
learning and modeling: Data, validation, communication challenges. Med Phys 45(10):
e834-e840, 2018. PMC6181755.
Feng M, Suresh K, Schipper MJ, Bazzi L, Ben-Josef E, Matuszak MM, Parikh ND, Welling
TH, Normolle D, Ten Haken RK, Lawrence TS: “Individualized Adaptive Sterotactic Body
Radiotherapy (SBRT) for Liver Tumors in Patients at High Risk for Liver Damage: A
Phase 2 Clinical Trial.” JAMA Oncol, 4(1):40-47, 2018, PMC5766368.
Ferrer-Torres D, Nancarrow DJ, Steinberg H, Wang Z, Kuick R, Weh KM, Mills RE, Ray
D, Ray P, Lin J, Chang AC, Reddy RM, Orringer MB, Canto MI, Shaheen NJ, Kresty LA,
Chak A, Wang TD, Rubenstein JH, Beer DG: “Constitutively Higher Level of GSTT2 in
Esophageal Tissues From African Americans Protects Cells Against DNA Damage.” Gastroenterology,
S0016-5085(18)35401-5, Dec 12 2018. PMID: 30578782.
Fritsche L, Beesley L, VandeHaar P, Peng R, Salvatore M, Zawistowski M, Taliun S,
LeFaive J, Kaleba E, Klumpner T, Moser S, Blanc V, Mukherjee B: “Exploring various
polygenic risk scores for skin cancer in the phenomes of the Michigan genomics initiative
and the UK Biobank with a visual catalog: PRSWeb”. Plos Genetics, 2019 June 13; 15(6):e1008202.
Hawkins PG*, Boonstra PS*, Hobson ST, Hayman JA, Ten Haken RK, Matuszak MM, Stanton
P, Kalemkerian GP, Lawrence TS, Schipper MJ, and Jolly S; ”Prediction of radiation
esophagitis in non-small cell lung cancer using clinical factors, dosimetric parameters,
and pretreatment cytokine levels.” Translational Oncology 11, 102–108. 2018. *Equal
contribution authors PMC6002355.
Hawkins PG, Tang M, Vineberg KA, Young L, Kovach K, Lee C, Maturen KE, Uppal S, Owen
D, Schipper MJ, Prisciandaro JI, Jolly S: “Dosimetric impact of interfractional organs
at risk variation during high-dose rate interstitial brachytherapy for gynecologic
malignancies.” Med Dosim: 2018. PM30336971.
Healy MA, Morris AM, Abrahamse P, Ward KC, Kato I, Veenstra CM: “The accuracy of chemotherapy
ascertainment among colorectal cancer patients in the surveillance, epidemiology,
and end results registry program.” BMC Cancer, 18(1):481, 2018,PMC5924509.
Heiden BT, Patel N, Nancarrow DJ, Hermann M, Brown RKJ, Orringer MB, Lin J, Chang
AC, Carrott PW, Lynch WR, Zhao L, Beer DG, Reddy RM; “Positron Emission Tomography
18F-Fluorodeoxyglucose Uptake Correlates with KRAS and EMT Gene Signatures in Operable
Esophageal Adenocarcinoma.” J Surg Res., 232:621-628. 2018.
Henry NL, Kidwell KM, Alsamarraie C, Bridges C, Kwiatkowski Clauw D, Smith E, Williams
D; “Pilot study of a proactive self-management program for symptom management in patients
with breast cancer.” Journal of Clinical Oncology Clinical Cancer Informatics. 2:1-12,
2018.
Hertz DL, Kidwell KM, Vangipuram K, Li F, Pai MP, Burness M, Griggs JJ, Schott AF,
Van Poznak C, Hayes DF, Smith EML, Henry NL; “Paclitaxel Plasma Concentration After
the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy.” Clinical Cancer
Research. 24(15): 3602-3610, 2018, PMC6386454.
Hoban CW, Beesley LJ, Bellile EL, Sun Y, Spector ME, Wolf GT, Taylor JMG, Shuman AG:
“Individualized outcome prognostication for patients with laryngeal cancer.” Cancer,
12494):706-716, 2018, PMC5800991.
Hussain M, Daighault-Newton S, Twardowski PW, Albany C, Stein MN, Kunju LP, Siddiqui
J, Wu YM, Robinson D, Lonigro RJ, Cao X, Tomlins SA, Mehra R, Cooney KA, Montgomery
B, Antonarakis ES, Shevrin DH, Corn PG, Whang YE, Smith DC, Caram MV, Knudsen KE,
Stadler WM, Feng FY, Chinnaiyan AM: “Targeting Androgen Receptor and DNA Repair in
Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.” 36(10):991-999,
J Clin Oncol, PMID: 29261439.
Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz
EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, Wallace RE,
Spratt DE, Hamstra DA: A multi-institutional phase 2 trial of prostate stereotactic
body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion
with patient-reported quality of life. Pract Radiat Oncol 8(1): 40-47, 2018. PM29304991.
Jackson WC, Suresh K, Tumati V, Allen SG, Dess RT, Salami SS, George A, Kaffenberger
SD, Miller DC, Hearn JWD, Jolly S, Mehra R, Hollenbeck BK, Palapattu GS, Schipper
M, Feng FY, Morgan TM, Desai NB, Spratt DE: “Intermediate Endpoints After Postprostatectomy
Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival.” Eur Urol: 2018.
PM29306514.
Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR, Schipper MJ, Feng M, Cuneo
KC, Lawrence TS, Owen D: “Comparison of Stereotactic Body Radiation Therapy and Radiofrequency
Ablation in the Treatment of Intrahepatic Metastases.” Int J Radiat Oncol Biol Phys
100(4): 950-958, 2018. PM29485074.
Jagsi R, Griffith KA, Bellon J, Woodward W, Horton J, Ho A, Feng F, Speers C, Overmoyer
B, Sabel M, Schott A, and Pierce LJ for the Translational Breast Cancer Research Consortium:
“Concurrent Veliparib with Chest Wall and Nodal Radiation Therapy in Patients with
Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter
Study.” J Clin Oncol, 36(13):1317-1322, 2018, PMID: 29558281.
Jagsi R, Ward K, Abrahamse P, Wallner L, Kurian A, Hamilton A, Katz S, Hawley S, “Unmet
need for clinician engagement regarding financial toxicity after diagnosis of breast
cancer.” Cancer, 124(18)3668-3676. 2018.
Jin X, Qin T, Zhao M, Bailey N, Liu L, Yang K, Ng V, Higashimoto T, Coolon R, Ney
G, Figueroa ME, Li Q: “Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to
dysregulate hematopoietic stem and progenitor cells.” Blood Adv, 2(11):1259-1271,
2018, PMC5998937.
Kanters AE, Morris AM, Abrahamse PH, Mody L, Suwanabol PA: “The Effect of Peer Support
on Colorectal Cancer Patients' Adherence to Guideline-Concordant Multidisciplinary
Care.” Dis Colon Rectum, 61(7):817-823, 2018, PMC5992023.
Katz S, Ward K, Hamilton A, Abrahamse P, Hawley S, Kurian A, “Association of Germline
Genetic Test Type and Results With Patient Cancer Worry After Diagnosis of Breast
Cancer.” JCO Precision Oncology, 2018.
Kidwell KM, Postow MA, Panageas KS; “Sequential, Multiple Assignment, Randomized Trial
Designs in Immuno-Oncology Research.” Clinical Cancer Research. 24(4): 730-736, 2018.
Koneva LA, Zhang Y, Virani S, Hall PB, McHugh JB, Chepeha DB, Wolf GT, Carey TE, Rozek
LS, Sartor MA: “HPV Integration in HNSCC Correlates with Survival Outcomes, Immune
Response Signatures, and Candidate Drivers.” Mol Cancer Res, 16(1):90-102, 2018, PMC5752568.
Kung TA, Kidwell KM, Speth K, Pang JC, Jagsi R, Levi B, Newman LA, Wilkes EG, Momoh
AO; “Radiation-Induced Skin Changes after Post-Mastectomy Radiation Therapy: A Pilot
Study on Indicators for Timing of Delayed Breast Reconstruction.”; Journal of Reconstructive
Microsurgery. 35(3): 209-215, 2018.
Kurian AW, Bondarenko I, Jagsi R, Friese CR, McLeod CM, Hawley ST, Hamilton AS, Ward
KC, Hofer TP, Katz SJ. “Recent Trends in Chemotherapy Use and Oncologists’ Treatment
Recommendations for Early-Stage, Breast Cancer.” J Natl Cancer Inst, 110(5):493-500,
2018, PMC5946952.
Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley
ST, Morrow M, Jagsi R, Katz SJ: “Uptake, Results, and Outcomes of Germline Multiple-Gene
Sequencing After Diagnosis of Breast Cancer.” JAMA Oncol. 4(8)1066-1072, 2018, PMID:
29801090.
Lee KL, Janz NK, Zikmund-Fisher BJ, Jagsi R, Wallner LP, Kurian AW, Katz SJ, Abrahamse
P, Hawley ST: “What Factors Influence Women's Perceptions of their Systemic Recurrence
Risk after Breast Cancer Treatment?” Med Decis Making, 38(1):95-106, 2018, PMC5764769.
Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L, Wen B, Shu
P, Sun D, Kleer C, Wicha M, Sabel M, Tao K, Wang G, Zou W; “Aerobic Glycolysis Controls
Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in
Triple-Negative Breast Cancer.” Cell Metab., 28(1):87-103. 2018.
Lin C, Lo M, Moody R, Jiang H, Harouaka R, Stevers N, Tinsley S, Gasparyan M, Wicha
M, Sun D, “Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast
cancer.” Cancer Letters, 438: 165-173. 2018 PMID: 30227220.
Linzey J, Bernard M, Pasternak A, Smith C, Miklja Z, Zhao L, Kumar-Sinha C, Paul A,
Harris N, Robertson P, Hoffman L, Chinnaiyan, Mody R and Koschmann C. “Development
of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology”
(2018). J Neuro-Oncology, 137 (1): 155-169. 2018.
Litzenberg DW, Muenz DG, Archer PG, Jackson WC, Hamstra DA, Hearn JW, Schipper MJ,
Spratt DE: “Changes in Prostate Orientation Due to Removal of a Foley Catheter.” Med
Phys, 45(4):1369-1378, 2018, PMID: 29474748.
Ludwig ML, Kulkarni A, Birkeland AC, Michmerhuizen NL, Foltin SK, Mann JE, Hoesli
RC, Devenport SN, Jewell BM, Shuman AG, Spector ME, Carey TE, Jiang H, Brenner JC,
“The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines.”
Oral Oncology, 87: 144-151. 2018. PMCID: PMC6349383.
Ma VT, Boonstra PS, Menghrajani K, Perkins C, Gowin KL, Mesa RA, Gotlib JR, and Talpaz,
M; “Treatment with JAK inhibitors in myelofibrosis patients nullifies the prognostic
impact of unfavorable cytogenetics.” Clinical Lymphoma, Myeloma, and Leukemia 18,
e201–e210. 2018. PMC 5927833.
Marcath LA, Kidwell KM, Robinson A, Feng L, Vangipuram K, Schott AF, Pai MP, Hayes
DF, Henry NL, Hertz DL; “Patients Carrying Low-activity CYP2C8 Genotypes have Shorter
Systemic Paclitaxel Exposure.” Pharmacogenomics. 20(2): 95-104, 2018.
Marcath LA, Xi J, Hoylman EK, Kidwell KM, Kraft SL, Hertz DL; “Comparison of nine
tools for screening drug-drug interactions of Oral Oncolytics” Journal of Oncology
Practice. 14(6): 368-374, 2018.
McCulloch MM, Muenz DG, Schipper MJ, Velec M, Dawson LA, Brock KK: “A simulation study
to assess the potential impact of developing normal tissue complication probability
models with accumulated dose.” Adv Radiat Oncol 3(4): 662-672, PMC6200914. 2018.
McMullen ER, Gonzalez ME, Skala SL, Tran M, Thomas D, Djomehri SI, Burman B, Kidwell
KM, Kleer CG; “CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas
of the breast.” Breast Cancer Research and Treatment. 172(3): 577-586, 2018.
Mendiratta-Lala M, Masch W, Shankar PR, Hartman HE, Davenport MS, Schipper MJ, Maurino
C, Cuneo KC, Lawrence TS, Owen D: “MR Imaging Evaluation of Hepatocellular Carcinoma
Treated with Stereotactic Body Radiation Therapy (SBRT): Long Term Imaging Follow-Up.”
Int J Radiat Oncol Biol Phys: 2018. PM30213751.
Mikell JK, Kaza RK, Roberson PL, Younge KC, Srinivasa RN, Majdalany BS, Cuneo KC,
Owen D, Devasia T, Schipper MJ, Dewaraja YK: Impact of Y PET gradient-based tumor
segmentation on voxel- 90 level dosimetry in liver radioembolization. EJNMMI Phys
5(1): 31, 2018. PM30498973/PMC6265358.
Miller M, Trickey A, Kin C, Hawley S, Abrahamse P, Morris A, “Coordination of Care
in Colorectal Cancer Patients: A Population-Based Study.” Journal of the American
College of Surgeons, 227(4)S141-S142. 2018.
Morrow M, Abrahamse P, Katz SJ: “Trend Analysis on Reoperation After Lumpectomy for
Breast Cancer-Reply.” JAMA Oncol, 4(5):747, 2018, PMID: 29423506.
Morrow M, Jagsi R, McLeod M, Shumway D, Katz S. “Surgeon Attitudes Toward the Omission
of Axillary Dissection in Early Breast Cancer: Has ACOSOG Z0011 Changed Clinical Practice?” JAMA
Oncol, 2018. PMC6248076.
Muller KE, Zhao L, Jorns JM; “Isolated Atypical Lobular Hyperplasia Diagnosed on Breast
Biopsy: Low Upgrade Rate on Subsequent Excision with Long-Term Followup.” Archives
of Pathology and Laboratory Medicine, 142(3):391-395. 2018.
Muenz D, Braun T, Taylor JMG; “Modeling adverse event counts in phase I clinical trials
of a cytotoxic agent”. Clin Trials, 15(4): 386-397, 2018, PMC6053332.
Skala SL, Arps DP, Zhao L, Cha KB, Wang M, Harms PW, Andea AA, Fullen DR, Chan MP;
“Comprehensive histopathological comparison of epidermotropic/dermal metastatic melanoma
and primary nodular melanoma.” Histopathology, 72(3):472-480. 2018.
Owen DR, Boonstra PS , Viglianti B, Balter J, Schipper MJ, Jackson W, El Naqa I, Jolly
S, Ten Haken RK, and Matuszak MM “Modeling patient-specific dose-function response
using SPECT/CT to personalize prediction of radiation-induced lung toxicity.” International
Journal of Radiation Oncology · Biology · Physics 102, 1265–1275; https://doi.org/10.1016/j.ijrobp.2018.05.049,
2018. PMC6202237
Owen DR, Boonstra PS, Viglianti BL, Balter JM, Schipper MJ, Jackson WC, El Naqa I,
Jolly S, Ten Haken RK, Kong FS, Matuszak MM: “Modeling Patient-Specific Dose-Function
Response for Enhanced Characterization of Personalized Functional Damage”. Int J Radiat
Oncol Biol Phys 102(4): 1265-1275, 2018. PM30108006/PMC6202237.
Qin T, Zhang Y, Zarins KR, Jones T, Virani S, Peterson LA, McHugh JB, Chepeha D,Wolf
GT, Laura S Rozek LS, Sartor MA: “Expressed HNSCC variants by HPV-status in a well-characterized
Michigan cohort.” Sci Rep, 8(1):11458, 2018, PMID: 30061624.
Reimers MA., Shango MM, Daignault-Newton S, “Pazopanib with low fat meal (PALM) in
advanced renal cell carcinoma” et al. Invest New Drugs (2018). https://doi.org/10.1007/s10637-018-0692-8
Resnicow K, Patel M, McLeod M, Katz S, Jagsi R. “Physician Attitudes About Cost Consciousness
for Breast Cancer Treatment: Differences by Cancer Sub-specialty.” Breast Cancer Res
Treat, 2018. PMID: 30259283.
Ropa J, Saha N, Chen Z, Serio J, Chen W, Mellacheruvu D, Zhao L, Basrur V, Nesvizhskii
AI and Muntean AG; “PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation
and transcriptional repression of Hoxa9 and Meis1 in acute myeloid leukemia.” Oncotarget,
9(31):22123-22136. 2018.
Rosko AJ, Birkeland AC, Bellile E, Kovatch KJ, Miller AL, Jaffe CC, Shuman AG, Chinn
SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, Prince MEP, Bradford CR, Wolf GT,
Chepeha DB, Spector ME: “Hypothyroidism and Wound Healing After Salvage Laryngectomy.”
Ann Surg Oncol, 25(5):1288-1295, PMC6002868.
Sapir E, Tao Y, Schipper MJ, Bazzi L, Novelli PM, Devlin P, Owen D, Cuneo KC, Lawrence
TS, Parikh ND, Feng M.: “Stereotactic Body Radiation Therapy as an Alternative to
Transarterial Chemoembolization for Hepatocellular Carcinoma.” Int J Rad Oncol Biol
Phys, 100(1):122-130, 2018, PMC5818982
Schmitd LB, Beesley LJ, Russo N, Bellile EL, Inglehart RC, Liu M, Romanowicz G, Wolf
GT, Taylor JMG, D'Silva NJ: “Redefining Perineural Invasion: Integration of Biology
With Clinical Outcome.” Neoplasia, 22;20(7):657-667, 2018, PMID: 29800815.
Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, Mukherjee B:
“Novel common genetic susceptibility loci for colorectal cancer” JNCI: Journal of
the National Cancer Institute, 111 (2), 146-157. 2018.
Schofield HK, Zeller J, Espinoza C, Halbrook CJ, Del Vecchio A, Magnuson B, Fabo T,
Daylan AEC, Kovalenko I, Lee HJ, Yan W, Feng Y, Karim SA, Kremer DM, Kumar-Sinha C,
Lyssiotis CA, Ljungman M, Morton JP, Galbán S, Fearon ER, Pasca di Magliano M: “Mutant
p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma.”
JCI Insight, 25;3(2). pii: 97422, 2018, PMC5821189.
Sehrawat A, Gao L, Wang Y, Bankhead A 3rd, McWeeney SK, King CJ, Schwartzman J, Urrutia
J, Bisson WH, Coleman DJ, Joshi SK, Kim DH, Sampson DA, Weinmann S, Kallakury BVS,
Berry DL, Haque R, Van Den Eeden SK, Sharma S, Bearss J, Beer TM, Thomas GV, Heiser
LM, Alumkal JJ: “LSD1 activates a lethal prostate cancer gene network independently
of its demethylase function.” Proc Natl Sci USA, 115(18):E4179-E4188, 2018, PMC5939079.
Shankar PR, Kaza RK, Al-Hawary MM, Masch WR, Curci NE, Mendiratta-Lala M, Sakala MD, Johnson
TD, Davenport MS. “Impact of Clinical History on Maximum PI-RADS Version 2 Score:
A Six-Reader 120-Case Sham History Retrospective Evaluation.” Radiology, 2018, PMID:
29664338.
Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N: “Current Challenges
and Opportunities in Treating Glioblastoma.” Pharmacol Rev, 70(3):412-445, 2018, PMC5907910.
Shi J, Wang X, Lyu L, Jiang H, Zhu HJ: “Comparison of protein expression between human
livers and the hepatic cell lines HepG2, Hep3B, and Huh7 using SWATH and MRM-HR proteomics:
Focusing on drug-metabolizing enzymes.” Drug Metab Pharmacokinet, 33(2):133-140, 2018,
PMID: 29610054.
Shumway DA, Griffith KA, Hawley ST, Katz SJ, Jagsi R: “Patient Views and Correlates
of Radiotherapy Omission in a Population-Based Sample of Older Women with Favorable
Prognosis Breast Cancer.” Cancer, 124(13):2714-2723, 2018, PMID: 29669187.
Spratt DE, Suresh K, Osawa T, Schipper M, Jackson WC, Abugharib A, Lebastchi A, Smith
D, Montgomery JS, Palapattu GS, Priya Kunju L, Wu A, Lew M, Tomlins SA, Chinnaiyan
AM, Weizer AZ, Hafez KS, Kaffenberger SD, Udager A, Mehra R: “Detailed pathologic
analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched
orchiectomy and retroperitoneal lymph node dissections.” Med Oncol, 5(3):21, 2018,
PMID: 29387987.
Sun Y, Hawkins PG, Bi N, Tewari M, Hearn JWD, Hayman JA, Kalemkerian GP, Lawrence
TS, Ten-Haken RK, Matuszak MM, Kong FM, Jolly S, Schipper MJ: “Serum MicroRNA Signature
Predicts Response to High-dose Radiation Therapy in Locally Advanced Non-Small-Cell
Lung Cancer.” Int J Radiat Oncol Biol Phys, 100(1):107-114, 2018, PMC5736451.
Suresh K, Owen D, Bazzi L, Jackson W, Ten Haken RK, Jackson W, Bazzi L, Ten Haken
RK, Lawrence TS, Cuneo K, Feng M, Schipper MJ: “Using Indocyanine Green to Predict
Liver Toxicity After Stereotactic Body Radiotherapy for Primary Hepatocellular Carcinoma.”
Int J Rad Oncol Biol Phys, 100(1):131-137, 2018, PMC5736416.
Svoboda LK, Teh SSK, Sud S, Kerk S, Zebolsky A, Treichel S, Thomas D, Halbrook CJ,
Lee HJ, Kremer D, Zhang L, Klossowski S, Bankhead AR, Magnuson B, Ljungman M, Cierpicki
T, Grembecka J, Lyssiotis CA, Lawlor ER: “Menin regulates the serine biosynthetic
pathway in Ewing sarcoma.” J Pathol, 245(3):324-336, 2018, PMID: 29672864.
Tamura S, Wang Y, Veeneman B, Hovelson D, Bankhead A 3rd, Broses LJ, Lorenzatti Hiles
G, Liebert M, Rubin JR, Day KC, Hussain M, Neamati N, Tomlins S, Palmbos PL, Grivas
P, Day ML: “Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib
in Bladder Cancer.” Bladder Cancer, 2018 Jan 20;4(1):77-90, 2018, PMC5798519.
Tran Q, Kidwell KM, Tsodikov A: “A joint model of cancer incidence, metastasis, and
mortality” Lifetime Data Anal, 24(3):385-406, 2018, PMID 28871363.
Veenstra CM, Abrahamse P, Wagner TH, Hawley ST, Banerjee M, Morris AM: “Employment
benefits and job retention: evidence among patients with colorectal cancer.” Cancer
Med, 7(3):736-745, 2018, PMC5852372.
Viglianti BL, Wale DJ, Wong KK, Johnson TD, Ky C, Frey KA, Gross MD. “Effects of Tumor
Burden on Reference Tissue Standardized Uptake for PET Imaging.” Radiology, 2018,
PMID: 29558296.
Wages N and Braun T. “Accuracy, Safety, and Reliability of Novel Phase I Designs
– Letter”. Clinical Cancer Research (24): 5482-5482, 2018. PMID: 29661774.
Wahl DR, Kim MM, Aryal MP, Hartman H, Lawrence TS, Schipper MJ, Parmar HA, Cao Y:
“Combining Perfusion and High B-value Diffusion MRI to Inform Prognosis and Predict
Failure Patterns in Glioblastoma.” Int J Radiat Oncol Biol Phys 102(4): 757-764, 2018.
PM29980414.
Wang Q, Yan R, Pinnell N, McCarter A C, Oh Y, Liu Y, Sha C, Garber N. F, Chen Y, Wu
Q, Ku C J, Tran I, Serna Alarcon A, Kuick R, Engel J D, Maillard I, Cierpicki T, Chiang
M Y “Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development”
Blood Journal, 132(12(): 1279-1292. 2018 PMC6148450.
Wilson MJ, Sen A, Bridges D, Turgeon DK, Brenner DE, Smith WL, Ruffin MT 4th, Djuric
Z; “Higher baseline expression of the PTGS2 gene and greater decreases in total colonic
fatty acid content predict greater decreases in colonic prostaglandin-E2 concentrations
after dietary supplementation with ω-3 fatty acids”Prostaglandins Leukot Essent Fatty
Acids. 2018 Dec;139:14-19. doi: 10.1016/j.plefa.2018.11.001. Epub, 2018. PMID: 30471768
Zhang Y,Pitchiaya S, Cieślik M, Niknafs YS, Tien JC, Hosono Y, Iyer MK, Yazdani S,
Subramaniam S, Shukla SK, Jiang X, Wang L, Liu TY, Uhl M, Gawronski AR, Qiao Y1, Xiao
L, Dhanasekaran SM, Juckette KM, Kunju LP, Cao X, Patel U, Batish M, Shukla GC, Paulsen
MT, Ljungman M, Jiang H, Mehra R, Backofen R, Sahinalp CS, Freier SM, Watt AT, Guo
S, Wei JT, Feng FY, Malik R, Chinnaiyan AM: “Analysis of the androgen receptor-regulated
lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.” Nat
Genet, 50(6):814-824, 2018, PMC5980762.
Zhao L, Wu W, Feng D, Jiang H, Nguyen X: “Bayesian Analysis of RNA-seq Data Using
a Family of Negative Binomial Models.” Bayesian Anal, 13(2)411-436, 2018.
